<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several laboratories have reported a significant reduction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced injury to hippocampal neurons in rodents treated with competitive and noncompetitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor-channel <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>This study examined the effects of the noncompetitive <z:chebi fb="68" ids="48706">antagonist</z:chebi> (+)-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-<z:chebi fb="0" ids="24783">imine</z:chebi> maleate (MK-801) in Mongolian gerbils subjected to 5 min of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In adult female gerbils, single doses of MK-801 injected 1 hr prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly (p less than 0.01) reduced damage to CA1 hippocampal neurons </plain></SENT>
<SENT sid="3" pm="."><plain>However, the drug rendered the postischemic animals <z:e sem="disease" ids="C0009421" disease_type="Disease or Syndrome" abbrv="">comatose</z:e> and hypothermic for several hours compared with the saline-treated animals </plain></SENT>
<SENT sid="4" pm="."><plain>In subsequent experiments, animals pretreated with MK-801 and maintained normothermic during and after forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> demonstrated no amelioration of hippocampal damage </plain></SENT>
<SENT sid="5" pm="."><plain>Gerbils not treated with MK-801, but kept hypothermic in the postischemic period to approximately the same degree (34.5 degrees C) and duration (8 hr) as was induced by MK-801 therapy showed significant (p less than 0.01) protection of CA1 neurons against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The neuroprotective activity of MK-801 against transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> appears to be largely a consequence of postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> rather than a direct action on <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor-channels </plain></SENT>
</text></document>